Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
Cancer diagnosis and evaluation of treatment in the genomic era

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.12.15
Views: 1795

Prof Richard Schilsky - Chief Medical Officer, American Society for Clinical Oncology (ASCO), USA

Prof Schilsky describes his talk at the 3rd EurocanPlatform Translational Research Course on what we need to know to establish a diagnosis, to determine a prognosis and select the best treatment for cancer patients, and how the approach to all of these has altered during the genomic era.

He also considers what significance this area has for clinical practice, what the next steps are and what obstacles exist.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation